Genmab A/S (GMAB)
28.20
+0.21
(+0.75%)
USD |
NASDAQ |
May 31, 16:00
28.19
-0.01
(-0.04%)
After-Hours: 20:00
Genmab Shareholders Equity (Quarterly): 4.701B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.701B |
December 31, 2023 | 4.693B |
September 30, 2023 | 4.406B |
June 30, 2023 | 4.196B |
March 31, 2023 | 3.980B |
December 31, 2022 | 3.927B |
September 30, 2022 | 3.523B |
June 30, 2022 | 3.437B |
March 31, 2022 | 3.409B |
December 31, 2021 | 3.379B |
September 30, 2021 | 3.321B |
June 30, 2021 | 3.241B |
March 31, 2021 | 3.167B |
December 31, 2020 | 3.160B |
September 30, 2020 | 2.913B |
June 30, 2020 | 2.696B |
March 31, 2020 | 2.126B |
December 31, 2019 | 2.106B |
September 30, 2019 | 1.834B |
June 30, 2019 | 1.262B |
March 31, 2019 | 1.221B |
December 31, 2018 | 1.228B |
September 30, 2018 | 1.101B |
June 30, 2018 | 1.064B |
March 31, 2018 | 1.078B |
Date | Value |
---|---|
December 31, 2017 | 1.011B |
September 30, 2017 | 865.29M |
June 30, 2017 | 836.74M |
March 31, 2017 | 719.14M |
December 31, 2016 | 686.40M |
September 30, 2016 | 592.08M |
June 30, 2016 | 560.49M |
March 31, 2016 | 535.37M |
December 31, 2015 | 510.73M |
September 30, 2015 | 458.43M |
June 30, 2015 | 416.36M |
March 31, 2015 | 375.20M |
December 31, 2014 | 331.92M |
September 30, 2014 | 329.59M |
June 30, 2014 | 320.24M |
March 31, 2014 | 324.83M |
December 31, 2013 | 122.07M |
September 30, 2013 | 92.88M |
June 30, 2013 | 86.68M |
March 31, 2013 | 83.90M |
December 31, 2012 | 67.92M |
September 30, 2012 | 63.78M |
June 30, 2012 | 69.43M |
March 31, 2012 | 76.43M |
December 31, 2011 | 84.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.262B
Minimum
Jun 2019
4.701B
Maximum
Mar 2024
3.274B
Average
3.350B
Median
Shareholders Equity (Quarterly) Benchmarks
Ascendis Pharma A/S | -257.21M |
Novo Nordisk A/S | 14.31B |
Galecto Inc | 28.16M |
Evaxion Biotech AS | 5.533M |
IO Biotech Inc | 115.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.306B |
Total Liabilities (Quarterly) | 605.09M |
Current Ratio | 12.46 |